ClinicalTrialsFinder

Relapsed Natural Killer/T-cell Lymphoma Clinical Trials in Seoul, Kangnamgu

1 recruitingSeoul, Kangnamgu, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy

Natural Killer/T-cell LymphomaRelapsed Natural Killer/T-cell LymphomaRefractory Natural Killer/T-cell Lymphoma
Won Seog Kim37 enrolled1 locationNCT04763616